Quick Answer
Fortress Biotech, Inc. reported Total Assets of $185.55 million for the year ending 2025.
- Fortress Biotech, Inc. showed an increase of +28.7% in Total Assets from 2024 to 2025.
- This data is from Fortress Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $26.81 million | Q1 2012: $18.04 million | Q2 2012: $38.49 million | Q3 2012: $48.09 million | Q1 2013: $45.46 million | Q2 2013: $68.78 million | Q3 2013: $107.11 million | Q1 2014: $94.90 million | Q2 2014: $90.87 million | Q3 2014: $88.01 million | Q1 2015: $90.45 million | Q2 2015: $83.70 million | Q3 2015: $86.86 million | Q1 2016: $104.91 million | Q2 2016: $98.06 million | Q3 2016: $145.42 million | Q1 2017: $211.91 million | Q2 2017: $249.85 million | Q3 2017: $245.09 million | Q1 2018: $265.08 million | Q2 2018: $236.87 million | Q3 2018: $224.92 million | Q1 2019: $200.54 million | Q2 2019: $227.26 million | Q3 2019: $221.59 million | Q1 2020: $228.76 million | Q2 2020: $268.57 million | Q3 2020: $295.88 million | Q1 2021: $391.04 million | Q2 2021: $418.16 million | Q3 2021: $407.83 million | Q1 2022: $407.93 million | Q2 2022: $363.96 million | Q3 2022: $323.56 million | Q1 2023: $263.55 million | Q2 2023: $180.72 million | Q3 2023: $150.55 million | Q1 2024: $164.65 million | Q2 2024: $145.69 million | Q3 2024: $127.09 million | Q1 2025: $178.07 million | Q2 2025: $159.90 million | Q3 2025: $181.41 million.
- Over the full 16 years of available data (2010 to 2025), Fortress Biotech, Inc.'s Total Assets has grown by 1,142.0%.
- Historical annual values: Fiscal year 2025: $185.55 million | Fiscal year 2024: $144.22 million | Fiscal year 2023: $167.53 million | Fiscal year 2022: $294.30 million | Fiscal year 2021: $396.50 million | Fiscal year 2020: $333.41 million | Fiscal year 2019: $226.42 million | Fiscal year 2018: $140.99 million | Fiscal year 2017: $245.95 million | Fiscal year 2016: $170.73 million | Fiscal year 2015: $118.61 million | Fiscal year 2014: $89.33 million | Fiscal year 2013: $100.58 million | Fiscal year 2012: $40.99 million | Fiscal year 2011: $23.38 million | Fiscal year 2010: $14.94 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: